RETROSPECTIVE ANALYSIS ON THE USE OF ACETYLSALICYLIC ACID IN THE PREVENTION OF PREECLAMPSIA IN A MUNICIPALITY OF GOIÁS
DOI:
https://doi.org/10.37951/2675-5009.2022v3i07.80Keywords:
PRE-ECLAMPSIA, PRENATAL, ASPIRIN, PREVALENCE, INFORMATION DISSEMINATIONAbstract
Objective: This study aims to analyze and quantify the use of ASA in pregnant women with a high risk of pre-eclampsia in a city of Goiás, a Brazilian state, between 2019 and 2020. Methodology: The study analyzed 400 prenatal records of the Health System of one city of Goiás and identified clinical criteria pre-defined by the International Federation of Gynecology and Obstetrics, which allowed to identify the indications and propaedeutics of the medication. Results: 147 pregnant women had an indication for use of prophylactic ASA and 92% of them did not receive the medication. Within the 8% medicated, there was no adequate prescription. In addition, among pregnant women with an indication, 85% started prenatal care on time for the introduction of the medication and, in the vast majority, it was not started. Conclusion: The dissemination of knowledge and the rate of prescription of acetylsalicylic acid are extremely low in the city of Goiás. Thus, the opportunity to prevent serious illness with a medication recommended by regulatory agencies is lost.